NCT06485622
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Arteriosclerosis Obliterans, +2 more
- Locations
-
- The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
Clinical trial condition
Arteriosclerosis Obliterans
Explore clinical trials studying Arteriosclerosis Obliterans. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Arteriosclerosis Obliterans trial results
Enrolling by Invitation
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
NCT07023965
- Conditions
- Arterial Occlusive Disease, Arterial Occlusive Diseases, Arteriosclerosis, +29 more
- Locations
-
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Chifeng Municipal Hospital Chifeng, Neimenggu, China
- zhongshan Hospital Affiliated of Dalian University Dalian, Shenyang, China
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China
Completed
Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
NCT00823849
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Arteriosclerosis Obliterans, +9 more
- Locations
-
- Peking University First Hospital Beijing, China
NCT01518205
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Arteriosclerosis Obliterans, +22 more
- Locations
-
- universita Verona Verona, Italy
NCT00712946
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Arteriosclerosis Obliterans, +2 more
- Locations
-
- Department of Anesthesiology and Intensive Care, Turku University Hospital Turku, Finland